 |
Log in to MyPRSA to View or Purchase this item.
Getting Down to Business: Novartis Raises It's Stock Among the Business & Financial Press
Source: SO08 Silver Anvil Award
Product Code: 6BW-0714B03
Organization/Author/Firm: Novartis, Ruder Finn, Inc.
Industry: Health - Medical - Pharmaceutical
Specialization(s): Investor Relations
Format: Campaign Case Study (Silver Anvil)
Summary
2007 Silver Anvil Award Winner – Investor Relations – Companies with sales of more than $500 million
What a difference a year makes. Swiss pharmaceutical giant Novartis faced a challenge: despite strong performance, blockbuster medicines, and leading R&D, U.S. investors and media were overlooking the company.
Novartis challenged Ruder Finn to raise awareness and favorability among investors by increasing positive coverage in targeted business and financial outlets. RF’s campaign drove record coverage and feature stories on Novartis, and secured the company’s inclusion on ‘best-of’ lists and 'hot' stock picks. Utilizing corporate financial, product, and pipeline announcements, coupled with strategic interviews with Novartis senior executives, Ruder Finn’s campaign helped drive an 11 percent increase in Novartis’s stock.
